Asia-Pacific stocks mixed as investors monitor coronavirus developments
October 22, 2020 at 19:38 PM EDT
The U.S. Food and Drug Administration approved Gilead Sciences' antiviral drug remdesivir for the virus. The intravenous drug has helped shorten the recovery time of some hospitalized Covid-19 patients.